Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset

References

• Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221–229
   PubMed Web of Science ®Google Scholar
• Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001; 414: 792–798
   PubMed Web of Science ®Google Scholar
• Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346–1355
   PubMed Web of Science ®Google Scholar
• Blohmé G, Nyström L, Arnqvist HJ, Lithner F, Littorin B, Olsson PO, Scherstén B, Wibell L, Ostman J. Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adult: Results from a 5-year prospective nationwide study of the 15–34 year age group in Sweden. Diabetologia 1992; 35: 55–62
   Google Scholar
• Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehjto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) project group. Diabetes Care 2000; 23: 1516–1526
   PubMed Web of Science ®Google Scholar
• Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, Du Caju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Dorchy H, Quartier E, Gorus FK. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index. Diabetologia 2001; 44: 40–47
   PubMed Web of Science ®Google Scholar
• Weets I, Kaufman L, Van Der Auwera B, Crenier L, Rooman RP, De Block C, Casteels K, Weber E, Coeckelberghs M, Laron Z, Pipeleers DG, Gorus FK. Seasonality in clinical onset of type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 2004; 26: 26
   Google Scholar
• Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002; 115: 18–29
   PubMed Web of Science ®Google Scholar
• Schrezenmeir J, Jagla A. Milk and diabetes. J Am Coll Nutr 2000; 19: 176S–190S
   PubMed Web of Science ®Google Scholar
• Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 2001; 109: 871–876
   PubMed Web of Science ®Google Scholar
• Couper JJ. Environmental triggers of type 1 diabetes. J Paediatr Child Health 2001; 37: 218–220
   PubMedGoogle Scholar
• Sanjeevi CB, Höök P, Landin-Olsson M, Kockum I, Dahlquist G, Lybrand TP, Lernmark Å. DR4 subtypes and their molecular properties in a population base study of Swedish childhood diabetes. Tissue Antigens 1996; 47: 275–283
   PubMedGoogle Scholar
• Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3: 235–249
   PubMed Web of Science ®Google Scholar
• Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: Dominant protection and parental transmission of allele of the insulin gene-linked minisatellite locus. J Autoimmunity 1996; 9: 415–421
   PubMed Web of Science ®Google Scholar
• Pugliese A, Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev 2002; 18: 13–25
   PubMed Web of Science ®Google Scholar
• Lowe RM, Graham J, Sund G, Kockum I, Landin-Olsson M, Schaefer JB, Torn C, Lernmark A, Dahlquist G. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Autoimmunity 2000; 32: 173–180
   PubMed Web of Science ®Google Scholar
• Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity?. Genes Immun 2000; 1: 170–184
   PubMed Web of Science ®Google Scholar
• Kyvik KO, Green A, Beck NH. Concordance rates of insulin dependent diabetes mellitus: A population based study of young Danish twins. BMJ 1995; 311: 913–917, [see comments]
   PubMed Web of Science ®Google Scholar
• Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengård J, Kesäniemi YA. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060–1067
   PubMed Web of Science ®Google Scholar
• LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002; 25: 505–511
   PubMedGoogle Scholar
• Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes—Follow-up of the Seattle Family Study. Diabetes 1999; 48: 170–175
   PubMed Web of Science ®Google Scholar
• Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet cell antibodies and prediction of insulin dependent diabetes. Lancet 1990; 335: 147–149
   PubMed Web of Science ®Google Scholar
• Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RA, Soeldner JS, Eisenbarth GS. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes 1995; 44: 1176–1179
   PubMedGoogle Scholar
• Petersen JS, Kyvik KO, Bingley PJ, Gale EA, Green A, Dyrberg T, Beck NH. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. BMJ 1997; 314: 1575–1579
   PubMedGoogle Scholar
• Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB, Eisenbarth GS. Genetic determination of islet cell autoimmunity in monozygotic twin. BMJ 1999; 318: 698–702
   PubMedGoogle Scholar
• Fava D, Gardner S, Pyke D, Leslie RD. Evidence that the age at diagnosis of IDDM is genetically determined. Diabetes Care 1998; 21: 925–929
   PubMedGoogle Scholar
• Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3–15
   PubMed Web of Science ®Google Scholar
• Ho E, Bray TM. Antioxidants, NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med 1999; 222: 205–213
   PubMed Web of Science ®Google Scholar
• West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000; 17: 171–180
   PubMed Web of Science ®Google Scholar
• Dierckx N, Horvath G, van Gils C, Vertommen J, van de Vliet J, De Leeuw I, Manuel-y-Keenoy B. Oxidative stress status in patients with diabetes mellitus: Relationship to diet. Eur J Clin Nutr 2003; 57: 999–1008
   PubMedGoogle Scholar
• Elhadd TA, Kennedy G, Hill A, McLaren M, Newton RW, Greene SA, Belch JJ. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab Res Rev 1999; 15: 405–411
   PubMed Web of Science ®Google Scholar
• Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563–1574
   PubMed Web of Science ®Google Scholar
• Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L, Pomahacova R. Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diabetes Complications 2003; 17: 7–10
   PubMed Web of Science ®Google Scholar
• Rocic B, Vucic M, Knezevic-Cuca J, Radica A, Pavlic-Renar I, Profozic V, Metelko Z. Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes. Exp Clin Endocrinol Diabetes 1997; 105: 213–217
   PubMed Web of Science ®Google Scholar
• Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J 1999; 13: 1845–1854
   PubMed Web of Science ®Google Scholar
• Tran PO, Parker SM, LeRoy E, Franklin CC, Kavanagh TJ, Zhang T, Zhou H, Vliet P, Oseid E, Harmon JS, Robertson RP. Adenoviral overexpression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress. J Biol Chem 2004; 279: 53988–53993, Epub 52004 Oct 53912
   PubMedGoogle Scholar
• Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61: 154–166
   PubMed Web of Science ®Google Scholar
• Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31: 273–300
   PubMed Web of Science ®Google Scholar
• Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999; 49: 156–164
   PubMed Web of Science ®Google Scholar
• Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: A review. Mutat Res 2000; 463: 247–283
   PubMed Web of Science ®Google Scholar
• de Bruin WC, Wagenmans MJ, Peters WH. Expression of glutathione S-transferase alpha, P1-1 and T1-1 in the human gastrointestinal tract Jpn. J Cancer Res 2000; 91: 310–316
   Google Scholar
• Standop J, Ulrich AB, Schneider MB, Buchler MW, Pour PM. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas. Pancreatology 2002; 2: 510–518
   PubMedGoogle Scholar
• Ulrich AB, Schmied BM, Standop J, Schneider MB, Lawson TA, Friess H, Andren-Sandberg A, Buchler MW, Pour PM. Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis, and pancreatic cancer. Pancreas 2002; 24: 291–297
   PubMed Web of Science ®Google Scholar
• Verlaan M, te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, Drenth JP. Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet A 2003; 120: 34–39
   Google Scholar
• Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, Matutes E, Catovsky D, Houlston R. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 2002; 99: 4216–4218
   PubMed Web of Science ®Google Scholar
• Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, Morgan GJ. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis 2000; 21: 43–47
   PubMed Web of Science ®Google Scholar
• Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study. Carcinogenesis 2005; 26: 395–401, Epub 2004 Nov 2004
   PubMedGoogle Scholar
• de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, de Vries EG, Sijmons RH, Hofstra RM, Kleibeuker JH. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002; 11: 1332–1352
   PubMed Web of Science ®Google Scholar
• Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: Interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 2001; 22: 1053–1060
   PubMed Web of Science ®Google Scholar
• Clapper ML. Genetic polymorphism and cancer risk. Curr Oncol Rep 2000; 2: 251–256
   PubMedGoogle Scholar
• Mattey DL, Hassell AB, Dawes PT, Jones PW, Yengi L, Alldersea J, Strange RC, Fryer AA. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: Evidence for interaction with glutathione S-transferase genes. Arthritis Rheum 2000; 43: 859–864
   PubMed Web of Science ®Google Scholar
• Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A, Alldersea J, Fryer AA, Strange RC. Smoking and disease severity in rheumatoid arthritis: Association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002; 46: 640–646
   PubMedGoogle Scholar
• Layton MA, Jones PW, Alldersea JE, Strange RC, Fryer AA, Dawes PT, Mattey DL. The therapeutic response to D-penicillamine in rheumatoid arthritis: Influence of glutathione S-transferase polymorphisms. Rheumatology 1999; 38: 43–47, (Oxford)
   PubMed Web of Science ®Google Scholar
• Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, Kruse TA. Possible gene dosage effect of glutathione-S-transferases on atopic asthma: Using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat 2004; 24: 208–214
   PubMed Web of Science ®Google Scholar
• Tamer L, Calikoglu M, Ates NA, Yildirim H, Ercan B, Saritas E, Unlu A, Atik U. Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 2004; 9: 493–498
   PubMed Web of Science ®Google Scholar
• Matheson MC, Stevenson T, Akbarzadeh S, Propert DN. GSTT1 null genotype increases risk of premenopausal breast cancer. Cancer Lett 2002; 181: 73–79
   PubMed Web of Science ®Google Scholar
• Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003; 544: 9–41
   PubMed Web of Science ®Google Scholar
• Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 2005; 11: 331–335
   PubMed Web of Science ®Google Scholar
• Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996; 20: 463–466
   PubMed Web of Science ®Google Scholar
• Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 2000; 49: 1123–1130
   PubMed Web of Science ®Google Scholar
• Rasilainen S, Nieminen JM, Levonen AL, Otonkoski T, Lapatto R. Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide. Biochem Pharmacol 2002; 63: 1297–1304
   PubMedGoogle Scholar
• Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Profozich J, Milton M, Ziegenfuss A, Trucco M, Piganelli JD. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559–2568
   Google Scholar
• Tiedge M, Lortz S, Munday R, Lenzen S. Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 1999; 42: 849–855
   PubMed Web of Science ®Google Scholar
• Tiedge M, Lortz S, Munday R, Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 1998; 47: 1578–1585
   PubMed Web of Science ®Google Scholar
• Bastar I, Seckin S, Uysal M, Aykac-Toker G. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol 1998; 102: 265–272
   PubMedGoogle Scholar
• Rabinovitch A. Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes. J Lab Clin Med 1992; 119: 455–456
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nyström L, Dahlquist G. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068–1073
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15–34 years old patients in the Diabetes Incidence Study in Sweden (DISS). Diabetes 1992; 41: 1022–1027
   PubMed Web of Science ®Google Scholar
• Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187–191
   PubMedGoogle Scholar
• Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159–1164
   PubMed Web of Science ®Google Scholar
• Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271–276
   PubMed Web of Science ®Google Scholar
• D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 1991; 19: 3749
   PubMed Web of Science ®Google Scholar
• Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark Å. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark Å. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113–125
   PubMed Web of Science ®Google Scholar
• Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GE. ICA512 autoantibody radioassay. Diabetes 1995; 44: 1340–1344
   PubMed Web of Science ®Google Scholar
• Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992; 41: 183–186
   PubMed Web of Science ®Google Scholar
• Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106: 83–88
   PubMed Web of Science ®Google Scholar
• Dahl-Jørgensen K, Joner G, Hanssen KF. Relationship between cow's milk consumption and incidence of IDDM in childhood. Diabetes Care 1991; 14: 1081–1083
   PubMed Web of Science ®Google Scholar
• Wasmuth HE, Kolb H. Cow's milk and immune-mediated diabetes. Proc Nutr Soc 2000; 59: 573–579
   PubMed Web of Science ®Google Scholar
• Virtanen SM, Laara E, Hypponen E, Reijonen H, Rasanen L, Aro A, Knip M, Ilonen J, Akerblom HK. Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: A nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes 2000; 49: 912–917
   PubMed Web of Science ®Google Scholar
• Pundziute-Lycka A, Persson LA, Cedermark G, Jansson-Roth A, Nilsson U, Westin V, Dahlquist G. Diet, growth, and the risk for type 1 diabetes in childhood: A matched case-referent study. Diabetes Care 2004; 27: 2784–2789
   PubMedGoogle Scholar
• Whincup PH, Cook DG, Adshead F, Taylor SJ, Walker M, Papacosta O, Alberti KG. Childhood size is more strongly related than size at birth to glucose and insulin levels in 10–11-year-old children. Diabetologia 1997; 40: 319–326
   PubMed Web of Science ®Google Scholar
• Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J, Pundziute-Lycka GA, et al. The Swedish Childhood Diabetes Study: Type I diabetes in the 0–34 years group in Sweden. Diabetologia 2002; 45: 783–791
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2004; 17: 17
   Google Scholar
• Ryoo K, Huh SH, Lee YH, Yoon KW, Cho SG, Choi EJ. Negative regulation of MEKK1-induced signaling by glutathione S-transferase. Mu J Biol Chem 2004; 279: 43589–43594, Epub 42004 Aug 43586
   PubMed Web of Science ®Google Scholar
• Dorion S, Lambert H, Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 2002; 277: 30792–30797, Epub 32002 Jun 30719
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Wolf CR, Kitteringham N, Powell H, Otto D, Park BK. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase. Pi Proc Natl Acad Sci USA 2000; 97: 12741–12745
   PubMed Web of Science ®Google Scholar
• Otto-Knapp R, Jurgovsky K, Schierhorn K, Kunkel G. Antioxidative enzymes in human nasal mucosa after exposure to ozone. Possible role of GSTM1 deficiency. Inflamm Res 2003; 52: 51–55
   PubMedGoogle Scholar
• Kubisch HM, Wang J, Bray TM, Phillipss JP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 1997; 46: 1563–1566
   PubMed Web of Science ®Google Scholar
• Slonim AE, Surber ML, Page DL, Sharp RA, Burr IM. Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes. J Clin Investig 1983; 71: 1282–1288
   PubMedGoogle Scholar
• Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998; 21: 1736–1742
   PubMed Web of Science ®Google Scholar
• Strokov IA, Bursa TR, Drepa OI, Zotova EV, Nosikov VV, Ametov AS. Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: A population-based case-control study. Acta Diabetol 2003; 40: S375–S379
   Google Scholar
• Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T. A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2003; 73: 435–455
   PubMed Web of Science ®Google Scholar
• Fujita H, Narita T, Meguro H, Shimotomai T, Kitazato H, Kagaya E, Sugasawa H, Hanyu O, Suzuki K, Ito S. No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Ren Fail 2000; 22: 479–486
   PubMed Web of Science ®Google Scholar
• Zotova EV, Savost'ianov KV, Chistiakov DA, Bursa TR, Galeev IV, Strokov IA, Nosikov VV. Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus. Mol Biol (Mosk) 2004; 38: 244–249
   PubMedGoogle Scholar
• Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G, Sichel F. GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 2004; 10: 3389–3393
   PubMedGoogle Scholar